Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 5, Number 5—October 1999
Dispatch

Acute Sin Nombre Hantavirus Infection without Pulmonary Syndrome, United States

Paul T. Kitsutani*Comments to Author , Robert W. Denton†, Curtis L. Fritz‡, Robert A. Murray§, Randall L. Todd¶#, W. John Pape**, J. Wyatt Frampton††, Joni C. Young*, Ali S. Khan*, Clarence J. Peters*, and Thomas G. Ksiazek*
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †Bishop, California, USA; ‡California Department of Health Services, Sacramento, California, USA; §California Department of Health Services, Berkeley, California, USA; ¶Bureau of Disease Control and Intervention Services, Carson City, Nevada, USA; #Nevada State Health Division, Carson City, Nevada, USA; **Colorado Department of Public Health & Environment, Denver, Colorado, USA; and ††Utah Department of Health, Salt Lake City, Utah, USA

Main Article

Table

Characteristics of five acute cases of Sin Nombre Virus infection without pulmonary syndrome, 1993–1999

Case 1 1993 Case 2 1998 Case 3 1999 Case 4 1998a Case 5 1993b
Age (yr) 38 36 19 32 4
Sex M F M M M
Race White White White White American Indian
State Nevada California Colorado Utah New Mexico
Hospitalized No No Yes Yes No
Symptoms
Fever +c + + + +
Headache + + – + –
Malaise + + – – –
Myalgia + + + + –
Cough + + + – +
Shortness of breath + – – – –
Chest/substernal pain – + – – –
Sore throat – + – – NRd
Nausea/vomiting + + + – NR
Dizziness + – + – NR
Photophobia – + –
Abdominal pain – – – – NR
Diarrhea – – – – NR
Arthralgia – – – + NR
Vital signs
Max temp (ºF) 102.5 104.0 103.1 102.8 100.6
Blood pressure normal normal normal normal NR
Lowest O2 sat. (RAe) 85% 94% 89.9% 94% NR
Laboratory results
Highest Hct (%) 47.0 44.7 50.2 44.4 40.2
Highest WBC 9,100 8,000 10,200 7,300 NRf
% seg. neutrophils 68 40 39 88
% bands 9 30 24
% lymphocytes 19 14 20 7
% atypical lymphocytes NR 4 NR NR
Lowest platelet (/mm3) 127,000 115,000 28,000 163,000 NRg
Highest SGOTh (U/L) NR 81 NR 26 NR
Highest LDHi (U/L) NR 337 488 240 NR
Lowest albumin (g/dL) NR 3.1 NR 4.3 NR
Chest X-ray 2-cm granuloma normal Mild left lower lobe infiltrate normal NR
Anti-SNVj antibody
IgM positive positive positive positive positive
IgG positive positive positive positive positive

aObtained from Zavasky D-M, Hjelle B, Peterson M, et al. Acute infection with Sin Nombre hantavirus without pulmonary edema. Clin Infect Dis, in press.
bObtained from Armstrong et al., 1995 (12).
c+, present; -, absent.
dNR = not recorded or obtained.
eRA = room air.
fPatient did not have leukocytosis.
gPatient did not have thrombocytopenia.
hSGOT = serum glutamic oxalacetic acid.
iLDH = lactic dehydrogenase.
jSNV = Sin Nombre virus.

Main Article

References
  1. Monroe  MC, Morzunov  SP, Johnson  AM, Bowen  MD, Artsob  H, Yates  T, Genetic diversity and distribution of Peromyscus-borne hantaviruses in North America. Emerg Infect Dis. 1999;5:75–86. DOIPubMedGoogle Scholar
  2. Centers for Disease Control and Prevention. Outbreak of acute illness-southwestern United States, 1993. MMWR Morb Mortal Wkly Rep. 1993;42:421–4.PubMedGoogle Scholar
  3. Khan  AS, Khabbaz  RF, Armstrong  LR, Holman  RC, Bauer  SP, Graber  J, Hantavirus pulmonary syndrome: the first 100 U.S. cases. J Infect Dis. 1996;173:1297–303.PubMedGoogle Scholar
  4. Duchin  JS, Koster  FT, Peters  CJ, Simpson  GL, Tempest  B, Zaki  SR, Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. N Engl J Med. 1994;330:949–55. DOIPubMedGoogle Scholar
  5. Hallin  GW, Simpson  SQ, Crowell  RE, James  DS, Koster  FT, Mertz  GJ, Cardiopulmonary manifestations of hantavirus pulmonary syndrome. Crit Care Med. 1996;24:252–8. DOIPubMedGoogle Scholar
  6. Zaki  SR, Greer  PW, Coffield  LM, Goldsmith  CS, Nolte  KB, Foucar  K, Hantavirus pulmonary syndrome: pathogenesis of an emerging infectious disease. Am J Pathol. 1995;146:552–79.PubMedGoogle Scholar
  7. Nolte  KB, Feddersen  RM, Foucar  K, Zaki  SR, Koster  FT, Madar  D, Hantavirus pulmonary syndrome in the United States: a pathological description of a disease caused by a new agent. Hum Pathol. 1995;26:110–20. DOIPubMedGoogle Scholar
  8. Simonsen  L, Dalton  MJ, Breiman  RF, Hennessy  T, Umland  ET, Sewell  CM, Evaluation of the magnitude of the 1993 hantavirus outbreak in the southwestern United States. J Infect Dis. 1995;172:729–33.PubMedGoogle Scholar
  9. Lee  HW, van der Groen  G. Hemorrhagic fever with renal syndrome. Prog Med Virol. 1989;36:62–102.PubMedGoogle Scholar
  10. Settergren  B. Nephropathia epidemica (hemorrhagic fever with renal syndrome) in Scandinavia. Rev Infect Dis. 1991;13:736–44.PubMedGoogle Scholar
  11. Armstrong  LR, Bryan  RT, Sarisky  J, Khan  AS, Rowe  T, Ettestad  PJ, Mild hantaviral disease caused by Sin Nombre virus in a four-year-old child. Pediatr Infect Dis J. 1995;14:1108–10. DOIPubMedGoogle Scholar
  12. Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance. MMWR Morb Mortal Wkly Rep. 1997;46(RR-10):16.
  13. Ksiazek  TG, Peters  CJ, Rollin  PE, Zaki  S, Nichol  S, Spiropoulou  C, Identification of a new North American hantavirus that causes acute pulmonary insufficiency. Am J Trop Med Hyg. 1995;52:117–23.PubMedGoogle Scholar
  14. Wells  RM, Young  J, Williams  RJ, Armstrong  LR, Busico  K, Khan  AS, Hantavirus transmission in the United States. Emerg Infect Dis. 1997;3:361–5. DOIPubMedGoogle Scholar
  15. Zeitz  PS, Butler  JC, Cheek  JE, Samuel  MC, Childs  JE, Shands  LA, A case-control study of hantavirus pulmonary syndrome during an outbreak in the southwestern United States. J Infect Dis. 1995;171:864–70.PubMedGoogle Scholar
  16. Ketai  LH, Williamson  MR, Telepak  RJ, Levy  H, Koster  FT, Nolte  KB, Hantavirus pulmonary syndrome: radiographic findings in 16 patients. Radiology. 1994;191:665–8.PubMedGoogle Scholar
  17. Ennis  FA, Cruz  J, Spiropoulou  CF, Waite  D, Peters  CJ, Nichol  ST, Hantavirus pulmonary syndrome: CD8+ and CD4+ cytotoxic T lymphocytes to epitopes on Sin Nombre virus nucleocapsid protein isolated during acute illness. Virology. 1997;238:380–90. DOIPubMedGoogle Scholar
  18. Simpson  SQ, Mapel  V, Koster  FT, Montoya  J, Bice  DE, Williams  AJ. Evidence for lymphocyte activation in the hantavirus pulmonary syndrome. Chest. 1995;106:97S.
  19. Gavrilovskaya  IN, Shepley  M, Shaw  R, Ginsberg  MH, Mackow  ER. ß3 integrins mediate the cellular entry of hantaviruses that cause respiratory failure. Proc Natl Acad Sci U S A. 1998;95:7074–9. DOIPubMedGoogle Scholar

Main Article

Page created: December 15, 2010
Page updated: December 15, 2010
Page reviewed: December 15, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external